<?xml version="1.0" encoding="UTF-8"?>
<p>This trial will be accomplished strictly followed the principles for medical ethics outlined in the 2013 updated Declaration of Helsinki. The study was approved by the Ethics and Research Committee of Chengdu Second People's Hospital, China (ethics reference: 2020077). This committee is an ethical approval committee organized by leading professors in their own fields. It will be obtained from all participants in advance that written and signed informed consent. This trial has been registered on 
 <ext-link ext-link-type="uri" xlink:href="http://www.chictr.org.cn/edit.aspx?pid=63281%26htm=4" xmlns:xlink="http://www.w3.org/1999/xlink">www.chictr.org.cn/edit.aspx?pid=63281&amp;htm=4</ext-link> (ChiCTR2000040942) at December 16, 2020 and will be reported squared with the CONSORT statement,
 <sup>[
  <xref rid="R19" ref-type="bibr">19</xref>]
 </sup> as well as STRICTA (Standards for Reporting Interventions in Clinical Trials of Acupuncture).
 <sup>[
  <xref rid="R20" ref-type="bibr">20</xref>]
 </sup> The Chinese Cochrane Center is responsible for the whole trial including the randomization, blinding, statistical analyses, data management, and monitoring.
</p>
